These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27554357)

  • 1. Protein-protein interaction inhibitors: advances in anticancer drug design.
    Ferreira LG; Oliva G; Andricopulo AD
    Expert Opin Drug Discov; 2016 Oct; 11(10):957-68. PubMed ID: 27554357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focusing on shared subpockets - new developments in fragment-based drug discovery.
    Abdelraheem EM; Camacho CJ; Dömling A
    Expert Opin Drug Discov; 2015; 10(11):1179-87. PubMed ID: 26296101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hot-spot analysis for drug discovery targeting protein-protein interactions.
    Rosell M; Fernández-Recio J
    Expert Opin Drug Discov; 2018 Apr; 13(4):327-338. PubMed ID: 29376444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Approaches Towards Kinases as Attractive Targets for Anticancer Drug Discovery and Development.
    Hameed R; Khan A; Khan S; Perveen S
    Anticancer Agents Med Chem; 2019; 19(5):592-598. PubMed ID: 30306880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of protein-protein interactions in drug discovery.
    Andrei SA; Sijbesma E; Hann M; Davis J; O'Mahony G; Perry MWD; Karawajczyk A; Eickhoff J; Brunsveld L; Doveston RG; Milroy LG; Ottmann C
    Expert Opin Drug Discov; 2017 Sep; 12(9):925-940. PubMed ID: 28695752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benchmark Study Based on 2P2I
    Wang Z; Kang Y; Li D; Sun H; Dong X; Yao X; Xu L; Chang S; Li Y; Hou T
    J Phys Chem B; 2018 Mar; 122(9):2544-2555. PubMed ID: 29420886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the challenges of protein flexibility in drug design.
    Antunes DA; Devaurs D; Kavraki LE
    Expert Opin Drug Discov; 2015 Dec; 10(12):1301-13. PubMed ID: 26414598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practices in Molecular Docking and Structure-Based Virtual Screening.
    Dos Santos RN; Ferreira LG; Andricopulo AD
    Methods Mol Biol; 2018; 1762():31-50. PubMed ID: 29594766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of quinoline as a privileged scaffold in cancer drug discovery.
    Musiol R
    Expert Opin Drug Discov; 2017 Jun; 12(6):583-597. PubMed ID: 28399679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Strategy Revealing the Structural Determinant of Ligand Selectivity towards Highly Similar Protein Targets.
    Wang H; Gao Y; Wang J; Cheng M
    Curr Drug Targets; 2020; 21(1):76-88. PubMed ID: 31556854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of experimental and computational structural approaches in 7TM drug discovery.
    Topiol S; Sabio M
    Expert Opin Drug Discov; 2015 Oct; 10(10):1071-84. PubMed ID: 26211671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicinal Chemistry Projects Requiring Imaginative Structure-Based Drug Design Methods.
    Moitessier N; Pottel J; Therrien E; Englebienne P; Liu Z; Tomberg A; Corbeil CR
    Acc Chem Res; 2016 Sep; 49(9):1646-57. PubMed ID: 27529781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated docking for novel drug discovery.
    Bello M; Martínez-Archundia M; Correa-Basurto J
    Expert Opin Drug Discov; 2013 Jul; 8(7):821-34. PubMed ID: 23642085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview on the current status on virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part II.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(6):1337-1358. PubMed ID: 28039691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Medicinal Chemistry to Human Health: Current Approaches to Drug Discovery for Cancer and Neglected Tropical Diseases.
    Ferreira LG; Oliva G; Andricopulo AD
    An Acad Bras Cienc; 2018; 90(1 Suppl 1):645-661. PubMed ID: 29451603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1.
    Rettenmaier TJ; Sadowsky JD; Thomsen ND; Chen SC; Doak AK; Arkin MR; Wells JA
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18590-5. PubMed ID: 25518860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using reverse docking for target identification and its applications for drug discovery.
    Lee A; Lee K; Kim D
    Expert Opin Drug Discov; 2016 Jul; 11(7):707-15. PubMed ID: 27186904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural products used as a chemical library for protein-protein interaction targeted drug discovery.
    Jin X; Lee K; Kim NH; Kim HS; Yook JI; Choi J; No KT
    J Mol Graph Model; 2018 Jan; 79():46-58. PubMed ID: 29136547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.